Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan

Page 10 of 17

8. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders In Q3 2024: 86

Merck & Co., Inc. (NYSE:MRK) is a pharmaceutical company whose been in the news for the past year or so because of a handful of drugs. These include its cancer treatment KEYTRUDA and HPV vaccine GARDASIL. Cramer’s previous comments about the firm have appreciated its GARDASIL drug. Like other healthcare companies, Merck & Co., Inc. (NYSE:MRK) has also struggled due to troubles in China. The firm’s GARDASIL distributor in the country has reduced inventories due to low demand. Cramer’s comments about the firm also revolved around China:

“And I thought that it was very encouraging, that, that Procter is seeing a turn there. It could also encourage Merck. Merck needs to have China be less of our enemy.”

Page 10 of 17